Latham Recognized With Six LMG Life Sciences Americas Awards Including Life Cycle Firm of the Year

Latham & Watkins was honored with six wins at the prestigious LMG Life Sciences Americas Awards — more than any other firm. These awards aim to recognize innovative and impactful work from across an array of legal specialties that influence the life sciences industry. Earlier this year, Latham was honored with six LMG Life Sciences EMEA Awards.

Latham’s Healthcare & Life Sciences Practice and its lawyers were named winners in the following categories:

• Life Cycle Firm of the Year — This is the third time in six years Latham has been honored with this significant award, which is given to firms that demonstrate strength across all critical areas of life sciences law.
• FDA Litigation & Enforcement Firm of the Year — Latham was honored for the firm’s extensive work in FDA litigation and enforcement.
• Regulatory Attorney of the Year — Global Chair of Latham’s Healthcare & Life Sciences Practice, John Manthei, was honored for his body of work assisting clients with all aspects of the FDA-regulated product life cycle.
• Antitrust Practitioner of the Year — Amanda Reeves, Office Managing Partner of the firm’s Washington, D.C. office was honored for her global leadership for life sciences clients who turn to her for representation in their toughest matters.
• Impact Case of the Year — Latham partners Gabriel Bell, Ken Schuler, Marc Zubick, and Herman Yue led a Latham team who was honored for successfully representing Avadel CNS in Jazz Pharmaceuticals, Inc. v. Avadel CNS Pharmaceuticals
• Impact Deal of the Year — A multidisciplinary team led by Charles Ruck and Daniel Rees advised Cereval Therapeutics in its US$8.7 billion acquisition by AbbVie in this award-winning deal. The transaction adds a wide range of best-in-class assets to AbbVie’s neuroscience pipeline that may transform standards of care across psychiatric and neurological disorders where significant unmet needs remain for patients.

Latham and its attorneys were shortlisted in an impressive 21 categories — more than any other firm — including Corporate Firm of the Year, M&A Firm of the Year, Licensing & Collaboration Firm of the Year, General Patent Litigation Firm of the Year, Government Investigations Firm of the Year, Intellectual Property Firm of the Year, and Antitrust Firm of the Year, as well as multiple lawyer of the year categories cross practices and jurisdictions. The LMG Life Sciences Awards are determined through rigorous research including firm submissions, practitioner surveys, client feedback, and independent research.

Latham’s cross-disciplinary healthcare and life sciences team delivers insightful, practical guidance, and sophisticated representation to a full spectrum of companies across the globe, on every type of transaction or dispute a company may face.